561 related articles for article (PubMed ID: 8102844)
1. Elevated risk of anaphylactoid reaction from radiographic contrast media is associated with both beta-blocker exposure and cardiovascular disorders.
Lang DM; Alpern MB; Visintainer PF; Smith ST
Arch Intern Med; 1993 Sep; 153(17):2033-40. PubMed ID: 8102844
[TBL] [Abstract][Full Text] [Related]
2. Increased risk for anaphylactoid reaction from contrast media in patients on beta-adrenergic blockers or with asthma.
Lang DM; Alpern MB; Visintainer PF; Smith ST
Ann Intern Med; 1991 Aug; 115(4):270-6. PubMed ID: 1677239
[TBL] [Abstract][Full Text] [Related]
3. Rates of hospitalizations and emergency department visits in patients with asthma and chronic obstructive pulmonary disease taking beta-blockers.
Brooks TW; Creekmore FM; Young DC; Asche CV; Oberg B; Samuelson WM
Pharmacotherapy; 2007 May; 27(5):684-90. PubMed ID: 17461703
[TBL] [Abstract][Full Text] [Related]
4. Use of beta-blockers during immunotherapy for Hymenoptera venom allergy.
Müller UR; Haeberli G
J Allergy Clin Immunol; 2005 Mar; 115(3):606-10. PubMed ID: 15753911
[TBL] [Abstract][Full Text] [Related]
5. An assessment of the association between carvedilol exposure and severe hypersensitivity reactions, angioedema, and anaphylactic reactions: a retrospective nested case-control analysis.
Koro CE; Sowell MD; Stender M
Clin Ther; 2012 Apr; 34(4):870-7. PubMed ID: 22444788
[TBL] [Abstract][Full Text] [Related]
6. Refractory anaphylactoid shock potentiated by beta-blockers.
Javeed N; Javeed H; Javeed S; Moussa G; Wong P; Rezai F
Cathet Cardiovasc Diagn; 1996 Dec; 39(4):383-4. PubMed ID: 8958428
[TBL] [Abstract][Full Text] [Related]
7. Beta-blockers and statins are individually associated with reduced mortality in patients undergoing noncardiac, nonvascular surgery.
Noordzij PG; Poldermans D; Schouten O; Schreiner F; Feringa HH; Dunkelgrun M; Kertai MD; Boersma E
Coron Artery Dis; 2007 Feb; 18(1):67-72. PubMed ID: 17172933
[TBL] [Abstract][Full Text] [Related]
8. Gender risk for anaphylactoid reaction to radiographic contrast media.
Lang DM; Alpern MB; Visintainer PF; Smith ST
J Allergy Clin Immunol; 1995 Apr; 95(4):813-7. PubMed ID: 7722160
[TBL] [Abstract][Full Text] [Related]
9. beta1- and beta2-adrenergic receptor gene variation, beta-blocker use and risk of myocardial infarction and stroke.
Lemaitre RN; Heckbert SR; Sotoodehnia N; Bis JC; Smith NL; Marciante KD; Hindorff LA; Lange LA; Lumley TS; Rice KM; Wiggins KL; Psaty BM
Am J Hypertens; 2008 Mar; 21(3):290-6. PubMed ID: 18219297
[TBL] [Abstract][Full Text] [Related]
10. Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD.
Dransfield MT; Rowe SM; Johnson JE; Bailey WC; Gerald LB
Thorax; 2008 Apr; 63(4):301-5. PubMed ID: 17951276
[TBL] [Abstract][Full Text] [Related]
11. Beta-blocker exposure is associated with improved survival after severe traumatic brain injury.
Cotton BA; Snodgrass KB; Fleming SB; Carpenter RO; Kemp CD; Arbogast PG; Morris JA
J Trauma; 2007 Jan; 62(1):26-33; discussion 33-5. PubMed ID: 17215730
[TBL] [Abstract][Full Text] [Related]
12. Perioperative beta-blocker withdrawal and mortality in vascular surgical patients.
Shammash JB; Trost JC; Gold JM; Berlin JA; Golden MA; Kimmel SE
Am Heart J; 2001 Jan; 141(1):148-53. PubMed ID: 11136500
[TBL] [Abstract][Full Text] [Related]
13. [Immediate and delayed hypersensitivity reactions to iodinated radiographic contrast agents: an update].
Khachman D; Gandia P; Sallerin F; Mailly N
Therapie; 2009; 64(5):331-9. PubMed ID: 19863909
[TBL] [Abstract][Full Text] [Related]
14. Beta-blocker underuse in secondary prevention of myocardial infarction.
Everly MJ; Heaton PC; Cluxton RJ
Ann Pharmacother; 2004 Feb; 38(2):286-93. PubMed ID: 14742768
[TBL] [Abstract][Full Text] [Related]
15. [Anaphylactic and anaphylactoid reactions occurring during anaesthesia in France. Seventh epidemiologic survey (January 2001-December 2002)].
Mertes PM; Laxenaire MC;
Ann Fr Anesth Reanim; 2004 Dec; 23(12):1133-43. PubMed ID: 15589352
[TBL] [Abstract][Full Text] [Related]
16. Beta-blocker therapy and the risk of anaphylaxis.
Toogood JH
CMAJ; 1987 May; 136(9):929-33. PubMed ID: 2882832
[TBL] [Abstract][Full Text] [Related]
17. Comparison of late mortality in hospitalized patients >70 years of age with systolic heart failure receiving beta blockers versus those not receiving beta blockers.
Pascual-Figal DA; Redondo B; Caro C; Manzano S; Garrido IP; Ruipérez JA; Valdés M
Am J Cardiol; 2008 Dec; 102(12):1711-7. PubMed ID: 19064029
[TBL] [Abstract][Full Text] [Related]
18. Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study.
Rejnmark L; Vestergaard P; Mosekilde L
J Hypertens; 2006 Mar; 24(3):581-9. PubMed ID: 16467662
[TBL] [Abstract][Full Text] [Related]
19. Does beta-blocker therapy improve clinical outcomes of acute myocardial infarction after successful primary angioplasty?
Kernis SJ; Harjai KJ; Stone GW; Grines LL; Boura JA; O'Neill WW; Grines CL
J Am Coll Cardiol; 2004 May; 43(10):1773-9. PubMed ID: 15145098
[TBL] [Abstract][Full Text] [Related]
20. Association of heart rate with microalbuminuria in cardiovascular risk patients: data from I-SEARCH.
Böhm M; Reil JC; Danchin N; Thoenes M; Bramlage P; Volpe M
J Hypertens; 2008 Jan; 26(1):18-25. PubMed ID: 18090536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
